Abiopharma

🔍 LUSTIG MATTHEW J (Director)

Company: Ventas, Inc. (VTR)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 396 shares of Common Stock at $82.01 per share (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 92,662.74 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan.
• F2: Represents the closing price per share of Issuer's common stock as of the grant date.